{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:49:01Z","timestamp":1791550141084,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ygyno.2024.05.003","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T07:25:48Z","timestamp":1715325948000},"page":"58-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinical outcomes with utilization of high-potency topical steroids in patients with lichen sclerosus-associated vulvar cancer"],"prefix":"10.1016","volume":"187","author":[{"given":"Nujsaubnusi C.","family":"Vue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Sassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Prairie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Krivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Crafton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Wield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary D.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirwen M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2024.05.003_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ijgo.12609","article-title":"Cancer of the vulva","volume":"143","author":"Rogers","year":"2018","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2024.05.003_bb0010","doi-asserted-by":"crossref","unstructured":"Francis JA, Eiriksson L, Dean E, Sebastianelli A, Bahoric B, Salvador S. No. 370-Management of Squamous Cell Cancer of the vulva. J. Obstet. Gynaecol. Can. 2019;41(1):89\u2013101. https:\/\/doi.org\/10.1016\/j.jogc.2018.07.004.","DOI":"10.1016\/j.jogc.2018.07.004"},{"key":"10.1016\/j.ygyno.2024.05.003_bb0015","author":"American Cancer Society"},{"key":"10.1016\/j.ygyno.2024.05.003_bb0020","author":"National Cancer Institute"},{"issue":"1","key":"10.1016\/j.ygyno.2024.05.003_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ogc.2018.09.008","article-title":"Vulvar Cancer","volume":"46","author":"Weinberg","year":"2019","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"issue":"6","key":"10.1016\/j.ygyno.2024.05.003_bb0030","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jaad.2019.07.055","article-title":"Diagnosis and management of vulvar cancer: a review","volume":"81","author":"Tan","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.05.003_bb0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ygyno.2018.03.003","article-title":"Vulvar cancer: two pathways with different localization and prognosis","volume":"149","author":"Hinten","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.05.003_bb0040","first-page":"230","article-title":"Clinical practice guidelines in oncology","volume":"15","author":"Koh","year":"2017","journal-title":"JNCCN J Natl Compr Cancer Netw."},{"issue":"1","key":"10.1016\/j.ygyno.2024.05.003_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.pgp.0000177646.38266.6a","article-title":"Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways","volume":"25","author":"Van Der Avoort","year":"2006","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.05.003_bb0050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ygyno.2011.07.010","article-title":"Residual anogenital lichen sclerosus after cancer surgery has a high risk for recurrence: a clinicopathological study of 75 women","volume":"123","author":"Regauer","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.05.003_bb0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/modpathol.2010.192","article-title":"Differentiated vulvar intraepithelial neoplasia is often found in lesions, previously diagnosed as lichen sclerosus, which have progressed to vulvar squamous cell carcinoma","volume":"24","author":"Van De Nieuwenhof","year":"2011","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.ygyno.2024.05.003_bb0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0029-7844(95)00045-S","article-title":"Prognostic significance of human papillomavirus DNA in vulvar carcinoma","volume":"85","author":"Monk","year":"1995","journal-title":"Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2024.05.003_bb0065","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1158\/1055-9965.EPI-09-0209","article-title":"The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned","volume":"18","author":"Van De Nieuwenhof","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ygyno.2024.05.003_bb0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/gyno.1994.1028","article-title":"Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance","volume":"52","author":"Ansink","year":"1994","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.05.003_bb0075","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jaad.2012.02.044","article-title":"Systematic review and meta-analysis of randomized controlled trials on topical interventions for genital lichen sclerosus","volume":"67","author":"Chi","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.05.003_bb0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.ygyno.2024.05.003_bb0085","article-title":"Of software platform partners","volume":"1\u201324","author":"Harris","year":"2020","journal-title":"J. Biomed. Inform."},{"issue":"9","key":"10.1016\/j.ygyno.2024.05.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.30621","article-title":"Lichen Sclerosus and risk of Cancer","volume":"140","author":"Halonen","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"2\u20133","key":"10.1016\/j.ygyno.2024.05.003_bb0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejcb.2004.12.003","article-title":"Immune dysregulation in lichen sclerosus","volume":"84","author":"Regauer","year":"2005","journal-title":"Eur. J. Cell Biol."},{"issue":"8","key":"10.1016\/j.ygyno.2024.05.003_bb0100","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1158\/1055-9965.EPI-16-0019","article-title":"Lichen sclerosus: incidence and risk of vulvar squamous cell carcinoma","volume":"25","author":"Bleeker","year":"2016","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"6","key":"10.1016\/j.ygyno.2024.05.003_bb0105","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.clindermatol.2013.05.017","article-title":"Influence of treatments on prognosis for vulvar lichen sclerosus: facts and controversies","volume":"31","author":"Brodrick","year":"2013","journal-title":"Clin. Dermatol."},{"issue":"12","key":"10.1016\/j.ygyno.2024.05.003_bb0110","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1471-0528.1990.tb02502.x","article-title":"The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women","volume":"97","author":"Leibowttch","year":"1990","journal-title":"BJOG An Int J Obstet Gynaecol."},{"issue":"5","key":"10.1016\/j.ygyno.2024.05.003_bb0115","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ejca.2008.11.037","article-title":"Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age","volume":"45","author":"van de Nieuwenhof","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2024.05.003_bb0120","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ajog.2019.10.095","article-title":"An arm-based network meta-analysis on treatments for vulvar lichen sclerosus and a call for development of core outcome sets","volume":"222","author":"Pergialiotis","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"March","key":"10.1016\/j.ygyno.2024.05.003_bb0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejogrb.2022.03.020","article-title":"Efficacy of topical progesterone versus topical clobetasol propionate in patients with vulvar lichen sclerosus \u2013 a double-blind randomized phase II pilot study","volume":"272","author":"G\u00fcnthert","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.05.003_bb0130","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/bjd.12910","article-title":"First randomized trial on clobetasol propionate and mometasone furoate in the treatment of vulvar lichen sclerosus: results of efficacy and tolerability","volume":"171","author":"Virgili","year":"2014","journal-title":"Br. J. Dermatol."},{"issue":"10","key":"10.1016\/j.ygyno.2024.05.003_bb0135","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jamadermatol.2015.0643","article-title":"Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women","volume":"151","author":"Lee","year":"2015","journal-title":"JAMA Dermatol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.05.003_bb0140","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ygyno.2019.05.010","article-title":"Margin status revisited in vulvar squamous cell carcinoma","volume":"154","author":"te Grootenhuis","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.05.003_bb0145","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/1097-0142(20000701)89:1<116::AID-CNCR16>3.0.CO;2-4","article-title":"Patterns of recurrence in patients with squamous cell carcinoma of the vulva: a multicenter CTF study","volume":"89","author":"Maggino","year":"2000","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2024.05.003_bb0150","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ygyno.2021.03.013","article-title":"Patterns of recurrence and survival in vulvar cancer: a nationwide population-based study","volume":"161","author":"Zach","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.05.003_bb0155","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ygyno.2005.03.006","article-title":"Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva","volume":"97","author":"Bosquet","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.05.003_bb0160","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ygyno.2021.02.025","article-title":"Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study","volume":"161","author":"Prieske","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.05.003_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2016.07.007","article-title":"Risk factors and treatment for recurrent vulvar squamous cell carcinoma","volume":"106","author":"Nooij","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.05.003_bb0170","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ygyno.2017.11.006","article-title":"Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: a systematic review","volume":"148","author":"te Grootenhuis","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.05.003_bb0175","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2016.06.019","article-title":"Adjacent lichen sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma","volume":"142","author":"Yap","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2024.05.003_bb0180","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1111\/jdv.14938","article-title":"Vulvar neoplasms in 275 women with genital lichen sclerosus and impact of treatment: a retrospective chart review","volume":"32","author":"Dell","year":"2018","journal-title":"J Eur Acad Dermatology Venereol."},{"issue":"7","key":"10.1016\/j.ygyno.2024.05.003_bb0185","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jamadermatol.2020.1074","article-title":"Association of Topical Corticosteroids with Reduced Vulvar Squamous Cell Carcinoma Recurrence in patient with vulvar lichen Sclerosus","volume":"156","author":"Chin","year":"2020","journal-title":"JAMA Dermatol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.05.003_bb0190","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2018.08.014","article-title":"The prognostic significance of p16 status in patients with vulvar Cancer treated with Vulvectomy and adjuvant radiation","volume":"103","author":"Dohopolski","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"22","key":"10.1016\/j.ygyno.2024.05.003_bb0195","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1158\/1078-0432.CCR-17-1302","article-title":"Genomic characterization of vulvar (pre)cancers identifies distinct molecular subtypes with prognostic significance","volume":"23","author":"Nooij","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2024.05.003_bb0200","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/LGT.0000000000000182","article-title":"Biomarkers p16, human papillomavirus and p53 predict recurrence and survival in early stage squamous cell carcinoma of the vulva","volume":"20","author":"Hay","year":"2016","journal-title":"J. Low. Genit. Tract Dis."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824002154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824002154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T09:42:05Z","timestamp":1745314925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824002154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":40,"alternative-id":["S0090825824002154"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.05.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes with utilization of high-potency topical steroids in patients with lichen sclerosus-associated vulvar cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}